* Single dose of RN0191 achieved up to 95% individual maximum and 87% mean maximum PCSK9 reductio...
* Financing led by LongRiver Investments with participation by new and existing global investment...
SHANGHAI, May 15, 2023 /PRNewswire/ -- Rona Therapeutics, Inc ("Rona") and Keymed Biosciences ("Key...
* Rona to advance worldwide development of Sanofi siRNA portfolio targeting liver and other tissu...
- Funding from long-term investors to build leading delivery platform and scalable drug discovery e...